Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock ...
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the company ...
Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an ...
With the addition of a low-profile device, the Surmodics Pounce thrombectomy platform can effectively remove clots from peripheral arteries with a diameter of 2 mm to 4 mm, including those located ...
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be ...
Stryker Corp. plans to pay $4.9 billion to acquire Inari Medical Inc., which makes devices to treat venous conditions.
Seasoned Medtech Executive to Expand Company Presence Into U.S. Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke ...
In essence, all of these devices are used to decrease the time taken for thrombus removal and possibly to reduce the risk of prolonged infusion (Box 1). Percutaneous mechanical thrombectomy (PMT ...
In addition, manual thrombectomy was associated with a lower ... to differences in patient selection, devices and study methodology. Moreover, many patients enrolled in these trials had a small ...
(NASDAQ: NARI) ("Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that on December 1, ...